Detalles de la búsqueda
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547895
2.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739879
3.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369901
4.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264544
5.
The Crying Need for a Better Response Assessment in Rectal Cancer.
Curr Treat Options Oncol
; 24(11): 1507-1523, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702885
6.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 23(5): 659-670, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427471
7.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(5): 665-677, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812497
8.
Efficacy of treatments for VIPoma: A GTE multicentric series.
Pancreatology
; 21(8): 1531-1539, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34404601
9.
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort.
Br J Clin Pharmacol
; 87(3): 1120-1128, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656857
10.
Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.
Acta Oncol
; 60(9): 1114-1121, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34197269
11.
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocol.
Colorectal Dis
; 23(7): 1909-1918, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33843133
12.
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
Br J Cancer
; 123(4): 518-524, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32507854
13.
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
Oncologist
; 25(2): e266-e275, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32043796
14.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32334548
15.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042063
16.
Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
Int J Colorectal Dis
; 33(7): 963-966, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675590
17.
When is the best moment to apply photobiomodulation therapy (PBMT) when associated to a treadmill endurance-training program? A randomized, triple-blinded, placebo-controlled clinical trial.
Lasers Med Sci
; 33(4): 719-727, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29185134
18.
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.
Ultraschall Med
; 39(5): 544-558, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29232725
19.
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).
Br J Cancer
; 117(7): 965-973, 2017 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817838
20.
Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
BMC Cancer
; 17(1): 901, 2017 12 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29282011